Previous 10 | Next 10 |
home / stock / lovff / lovff news
Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million Canada NewsWire Three- and nine-month net revenue were $15.9 million and $39 .3 million, a 57% and 63% increase compared to the same perio...
Montreal, Quebec--(Newsfile Corp. - May 23, 2023) - Cannara Biotech Inc (TSXV: LOVE) announced today that it will be presenting at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, California on June 6th-8th, 2023. The event is expected to feature 150+ companies, present...
Cannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis Conference Canada NewsWire MONTREAL , May 11, 2023 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically...
CANARA BIOTECH INC. SECURES AN ADDITIONAL $10 MILLION IN NON-DILUTIVE CAPITAL WITH ITS LEAD CREDIT PROVIDER, BMO COMMERCIAL BANKING Canada NewsWire MONTREAL , May 4, 2023 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQ...
Cannara Biotech Inc. to Host Investor Webcast on May 4th, 2023 Canada NewsWire MONTREAL , April 25, 2023 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-...
2023-04-24 09:29:36 ET Cannara Biotech press release ( OTCQB:LOVFF ): Q2 GAAP EPS of -$0.01. Revenue of $13M (+79.8% Y/Y). For further details see: Cannara Biotech GAAP EPS of -$0.01, revenue of $13M
Cannara Biotech Inc. reports Q2 2023 Financial Results with quarterly net revenues of $13 million, a 76% increase compared to Q2 2022 Canada NewsWire Six-month net revenues of $23.4 million , a 67% increase compared to first half 2022 Delivered its eighth consecutive qua...
Cannara Biotech Inc. Enters into an Automatic Share Purchase Plan Canada NewsWire MONTREAL , Feb. 28, 2023 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premiu...
CANNARA BIOTECH INC. ANNOUNCES RESULTS OF ANNUAL SHAREHOLDER MEETING AND CONVERSION INTO EQUITY OF A $5M CONVERTIBLE DEBENTURE AT $0.18 CENT PER COMMON SHARE Canada NewsWire MONTREAL , Feb. 10, 2023 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Com...
The Daily Hit is a recap of the top financial news stories for January 24, 2023. On the Site FDA Releases Cannabis Industry Research Guidance The guidance document from the U.S. Food and Drug Administration follows the 2018 federal legalization of hemp via that year’s feder...
News, Short Squeeze, Breakout and More Instantly...
Cannara Biotech Inc Company Name:
LOVFF Stock Symbol:
OTCMKTS Market:
Cannara Biotech Inc. (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0) announced its fiscal second quarter 2024 financial and operating results for the three a...
Cannara Biotech Reports Q2 2024 Financial Results Canada NewsWire Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase. Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4...
--News Direct-- Cannara Biotech Inc CFO Nicholas Sosiak joined Steve Darling from Proactive to provided valuable insights into the company's success in the cannabis industry. Cannara, based in Montreal, Canada, is a licensed producer with two facilities totaling 1.6 million square fee...